| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-213 |
|---|
|
| Excerpt |
|---|
|
Example of a Study with a Nonfixed Duration Element |
This example includes the nonfixed duration for pretest phase where the end rule is not a definite time, but when the subject achieves a specified body weight. In order to completely understand the experimental design of a trial, the TA and TS datasets are needed.
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | ETCD | ELEMENT | TESTRL | TEENRL | TEDUR |
|---|
| 1 | EXP7 | TE | PRETEST | Pretreatment Feeding Period | Start of pre-exposure period | When subject's body weight is at least 750 g |
| | 2 | EXP7 | TE | CONTROL | Control Period | After completion of PRETEST Element | 30 days after start of Element | P30D | | 3 | EXP7 | TE | TREAT2 | 100 mg/kg Drug A, once daily | After completion of PRETEST Element | 30 days after start of Element | P30D | | 4 | EXP7 | TE | TREAT3 | 200 mg/kg Drug A, once daily | After completion of PRETEST Element | 30 days after start of Element | P30D | | 5 | EXP7 | TE | TREAT4 | 300 mg/kg Drug A, once daily | After completion of PRETEST Element | 30 days after start of Element | P30D | | 6 | EXP7 | TE | TREAT5 | 100 mg/kg Drug B, twice daily doses of 50 mg/kg each | After completion of PRETEST Element | 30 days after start of Element | P30D | | 7 | EXP7 | TE | TREAT6 | 200 mg/kg Drug B, twice daily doses of 100 mg/kg each | After completion of PRETEST Element | 30 days after start of Element | P30D | | 8 | EXP7 | TE | TREAT7 | 400 mg/kg Drug B, twice daily doses of 200 mg/kg each | After completion of PRETEST Element | 30 days after start of Element | P30D | | 9 | EXP7 | TE | RECOVERY | Recovery Period | After last dose with product or vehicle control | 14 days after start of Element | P14D |
|
|